Category: Research
-
CAR-T cell therapy in brain tumour treatment
CAR-T cell therapy is a type of immunotherapy that may be promising for treating brain tumours. There is lots of research in this field across the globe and it may one day be used more widely to treat this devastating disease.
-
Two family charities fund £400,000 towards paediatric research in memory of their sons
The Brain Tumour Charity are delighted to announce a new partnership with two Family Led Charities that share the same aims of improving outcomes for children diagnosed with high grade brain tumours
-
The ARISTOCRAT clinical trial – perspective from a patient advocate
Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.
-
“It changes everything” – the impact of living with a lower-grade glioma
Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.
-
Emily Oliver’s Fighting Fund donates towards pioneering DIPG research
Donations made in Emily’s name, who died of the most aggressive form of childhood cancer, will fund research aimed at improving survival rates for the disease.
-
Nanotechnology could help understand how glioblastomas respond to treatment
A new nanosurgical tool – about 500 times thinner than a human hair – could help us understand how glioblastomas become resistant to radio- and chemotherapy. Up until now, no other technology has been able to do this.
-
Finding new drugs for treating glioblastoma
In 2019, we awarded £2.96 million to Professor Neil Carragher in collaboration with Cancer Research UK as part of £6 million of funding for vital research into glioblastoma.
-
Future Leader presents her work at the world’s largest neuro-oncology conference
Dr Veronica Rendo, a researcher funded by The Brain Tumour Charity, shared the findings of her work at the annual meeting of the Society for Neuro-Oncology.
-
The Cancer Tech Accelerator
We are pleased to announce that The Brain Tumour Charity has joined the Cancer Tech Accelerator 3.0 as a new funding partner!
-
Dabrafenib and trametinib – a new treatment on the horizon?
Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas.
-
Celebrating our award-winning researchers
Two of our funded researchers have won awards at the Society for Immunotherapy of Cancer (SITC) annual conference!
-
“Carpe Diem, that motto is important to me. I live in the moment”
Natalie McKenna-Mounty was diagnosed with a glioblastoma in 2020, her tumour returned in June this year, and now she is supporting our new research funding to find better glioblastoma treatments.
-
Future Leaders: Junior Fellowship Funding Announcement
We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!
-
The Ways Ahead project – finding better ways to support people with their diagnosis
The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.
-
The Be More Laura Foundation pledges £25,000 towards pioneering research
The Be More Laura Foundation has donated to The Brain Tumour Charity £25,000 to help fund our pioneering ARISTOCRAT clinical trial in memory of Laura Nuttall.
-
Sheffield scientists take on Sheffield 10K to raise money
Researchers from the University of Sheffield ran the Sheffield 10K on 24th September to raise money for us, a charity close to their hearts.
-
Shifting the dial on inclusion in medical research
This Black History Month we’re examining ways The Brain Tumour Charity can help work towards making participation in medical research more inclusive.
-
The BRAIN MATRIX study identifies urgent need for improvement in healthcare services
Researchers involved in the Tessa Jowell BRAIN MATRIX study are calling for improvements to speed up the way brain tumours are diagnosed.
-
Quest for Cures funding announcement
We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.
-
Scientists at the Everest Centre to transform treatments for childhood brain tumours
Experts at University College London, Queen Mary University of London and Great Ormond Street Hospital are to develop pioneering treatments for children diagnosed with low-grade brain tumours.
-
Recent clinical trial suggests the drug vorasidenib could offer a new treatment option for low-grade glioma.
An international phase 3 clinical trial has shown that a new targeted therapy to treat low-grade gliomas can slow the progression of the disease. These findings have the potential to offer a new treatment option for those diagnosed with a grade 2 glioma.
-
Whole genome sequencing – what is it and how could it help?
Whole genome sequencing is the scientific term used when scientists sequence DNA.
-
BRAIN MATRIX: Pioneering research to improve treatments for gliomas
Researchers at the University of Birmingham are paving the way to improve brain tumour treatment in a revolutionary study which collects detailed information about a person’s tumour.
-
Key biomarker for aggressive meningiomas identified by researchers
Researchers at the University of Toronto have identified a biomarker that can predict how aggressive meningiomas may be in those diagnosed with this type of brain tumour.